Skip to main content

HubXchange

HubXChange logo

Immunotherapies Xchange - San Francisco - 2025

Page Banner 1

  1. Immune Biomarkers
    • Immune Biomarkers
    AI-powered multiplex biomarker interpretation pipelines
    Dinesh Kumar, Ph.D
    Dinesh Kumar, Ph.D, Head of Translational Research Bioinformatics - Roche
  2. Immune Biomarkers
    • Immune Biomarkers
    Poster Presentation:
  3. Immune Regulation
    • Immune Regulation
    Poster Presentation:
  4. Clinical Development
    • Clinical Development
    Clinical Trials in Rare Oncology Disease Indications
    Is the inclusion of a control arm appropriate in rare indications? What role would synthetic arms ap ...
    Anthony Maida
    Anthony Maida, Chief Clinical Officer - Translational Medicine - Oncotelic Therapeutics
  5. Immune Biomarkers
    • Immune Biomarkers
    Advancing neoantigen identification and immune monitoring: From discovery to clinical validation
    Léila Delamarre
    Léila Delamarre, Distinguished Scientist and Director, Cancer Immunology Discovery - Genentech
  6. Translational Immunology
    • Translational Immunology
    Poster Presentation:
  7. Clinical Development
    • Clinical Development
    Assessing clinical trial designs in advancing novel immunotherapeutic drugs
    Evaluating adaptive trial designs to accelerate immunotherapy development Balancing safety and effic ...
    Venita DeAlmeida
    Venita DeAlmeida, Clinical Science Lead - 3T Biosciences
  8. Clinical Development
    • Clinical Development
    Poster Presentation:
  9. Immunogenicity
    • Immunogenicity
    Poster Presentation:
  10. Immune Regulation
    • Immune Regulation
    Designing synthetic gene circuits for programmable immune tolerance

    Iqvia Laboratories

  11. Translational Immunology
    • Translational Immunology
    IL-10's translational implications in human biology (Topic TBC)
    Vikash J. Bhagwandin
    Vikash J. Bhagwandin, Founding Scientist - VincaStemyx
  12. Immune Regulation
    • Immune Regulation
    Expanding and transferring regulatory T cells to enhance immune tolerance
    Strategies to efficiently expand regulatory T cells ex vivo for therapeutic use Optimizing Treg stab ...
    Olivier Nolan-Stevaux, Ph.d,
    Olivier Nolan-Stevaux, Ph.d,, Senior Director, Oncology Research - Gilead Sciences, Inc.
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Afternoon Refreshments
  14. Translational Immunology
    • Translational Immunology
    Immunotherapy for autoimmune disease: from bulk depletion to precision medicine
    CAR T cell therapy: CD19 or other B cell subsets? discussion of CAR targets NK cells: natural contro ...
    Stefanie Mandl-Cashman
    Stefanie Mandl-Cashman, Chief Science Officer - Indapta Therapeutics
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Evening Drinks Reception
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Spotlight Presentation: Engineering Unique Properties in Next-Gen Antibody Therapies
    Spotlight Presentation: Engineering Unique Properties in Next-Gen Antibody Therapies
    We will explore some of the cutting-edge advancements in our antibody discovery and engineering appr ...
    Jordon Wang
    Jordon Wang, Chief Operating Officer - Avantgen
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Networking Lunch
  20. Translational Immunology
    • Translational Immunology
    Translating immune aging research into therapeutic interventions

    Ultivue

    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Morning Refreshments
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
  24. Immune Regulation
    • Immune Regulation
    Immune metabolic pathways in maintaining tolerance
    Recent advances in our understanding of immune cell metabolic pathways, and their driving role in in ...
    Greg Timblin
    Greg Timblin, CEO & Co-Founder - Inapill
  25. Clinical Development
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Spotlight Presentation:
    Spotlight Presentation:
  26. Immunogenicity
    • Immunogenicity
    Modulating the immune response to prevent immunogenicity/anti-drug antibodies [Topic TBC]
    Bala Medicherla
    Bala Medicherla, Director, BioAnalytics - Astellas Gene Therapies
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Opening Address & Keynote Presentation: Potency Assay Technical Transfer Best Practice
    Potency assays measure the biological activity of biological products, providing data on drug dose, ...
    Joe Newcome
    Joe Newcome, Senior Director - Minaris Advanced Therapies
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Registration
Search